+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Psoriasis Drugs Market Research Reports

From
From
From
From
From
Psoriasis - Pipeline Insight, 2024 - Product Thumbnail Image

Psoriasis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 100 Pages
  • Global
From
Chronic Plaque Psoriasis - Pipeline Insight, 2024 - Product Thumbnail Image

Chronic Plaque Psoriasis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Plaque Psoriasis - Pipeline Insight, 2024 - Product Thumbnail Image

Plaque Psoriasis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 240 Pages
  • Global
From
Phototherapies for Psoriasis - Pipeline Insight, 2024 - Product Thumbnail Image

Phototherapies for Psoriasis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Psoriasis vulgaris - Pipeline Insight, 2024 - Product Thumbnail Image

Psoriasis vulgaris - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Moderate to Severe Plaque Psoriasis - Pipeline Insight, 2024 - Product Thumbnail Image

Moderate to Severe Plaque Psoriasis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Severe Psoriasis - Pipeline Insight, 2024 - Product Thumbnail Image

Severe Psoriasis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Moderate Psoriasis - Pipeline Insight, 2024 - Product Thumbnail Image

Moderate Psoriasis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
Adalimumab Drugs Market Report and Forecast 2024-2032 - Product Thumbnail Image

Adalimumab Drugs Market Report and Forecast 2024-2032

  • Report
  • February 2024
  • 140 Pages
  • Global
From
From
Plaque Psoriasis (Psoriasis Vulgaris) - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Plaque Psoriasis (Psoriasis Vulgaris) - Global Clinical Trials Review, 2024

  • Clinical Trials
  • August 2024
  • 1218 Pages
  • Global
From
Generalized Pustular Psoriasis (GPP) - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Generalized Pustular Psoriasis (GPP) - Global Clinical Trials Review, 2024

  • Clinical Trials
  • August 2024
  • 70 Pages
  • Global
From
Generalized Pustular Psoriasis (GPP) - Competitive Landscape - Product Thumbnail Image

Generalized Pustular Psoriasis (GPP) - Competitive Landscape

  • Report
  • December 2023
  • 78 Pages
  • Global
From
Loading Indicator

The Psoriasis Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat psoriasis, a chronic skin condition. Psoriasis is characterized by red, scaly patches on the skin, and can cause itching, burning, and pain. Psoriasis drugs are designed to reduce inflammation, reduce the rate of skin cell growth, and reduce the severity of symptoms. The Psoriasis Drugs market is highly competitive, with many companies offering a variety of treatments. Some of the major players in the market include AbbVie, Amgen, Celgene, Janssen, and Novartis. These companies offer a range of treatments, including topical creams, oral medications, and biologic drugs. Other companies in the market include Sun Pharmaceuticals, Glenmark Pharmaceuticals, and Lupin Pharmaceuticals. Show Less Read more